Digest Network How does it work
Network
/
Society
CY
Not verified

CYBIN Inc.

What we write about

BiotechnologyHealthMedicine - variousPharmaceuticalsPsychiatry

30 Press releases

View all press releases
15/05/2025
Labour market
Industria
Psychiatry
Health
Sanità
Medicine - various
Pharmaceuticals
Biotechnology
Cybin Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for its CYB003 Program for the Adjunctive Treatment of Major Depressive Disorder
Source
CYBIN Inc.
Issuer
Business Wire
1.00
0
14/05/2025
WEB AND SOCIAL NETWORK
Industria
Eventi
Alternative Medicine
Psychiatry
Health
Medicine - various
Pharmaceuticals
Biotechnology
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase
Source
CYBIN Inc.
Issuer
Business Wire
1.00
0
08/05/2025
Industria
Alternative Medicine
Psychiatry
Health
Medicine - various
Pharmaceuticals
Biotechnology
Cybin Announces Additional U.S. Patent Supporting its CYB003 Breakthrough Therapy Program in Phase 3 Development for Major Depressive Disorder
Source
CYBIN Inc.
Issuer
Business Wire
1.00
0
01/05/2025
WEB AND SOCIAL NETWORK
Eventi
Pharmaceuticals
Health
Psychiatry
Cybin to Participate at the 28th Annual Milken Institute Global Conference
Source
CYBIN Inc.
Issuer
Business Wire
1.00
0
23/04/2025
Labour market
Psychiatry
Health
Medicine - various
Scienza
Pharmaceuticals
Cybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003
Source
CYBIN Inc.
Issuer
Business Wire
1.00
0
21/04/2025
Labour market
Industria
Software
Computer networks
Pharmaceuticals
Information Technology
Psychiatry
Tecnica
Medicine - various
Biotechnology
Management
Health
Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs
Source
CYBIN Inc.
Issuer
Business Wire
1.00
0
11/02/2025
Biotechnology
Pharmaceuticals
Health
Psychiatry
stock market
Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
Source
CYBIN Inc.
Issuer
Business Wire
1.00
0
15/01/2025
Labour market
Industria
Psychiatry
Health
Sanità
Medicine - various
Pharmaceuticals
Biotechnology
Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
Source
CYBIN Inc.
Issuer
Business Wire
1.00
0
13/01/2025
Psychiatry
Health
Medicine - various
Pharmaceuticals
Biotechnology
Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025
Source
CYBIN Inc.
Issuer
Business Wire
1.00
0
09/01/2025
WEB AND SOCIAL NETWORK
Eventi
Alternative Medicine
Psychiatry
Health
Medicine - various
Pharmaceuticals
Biotechnology
Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
Source
CYBIN Inc.
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0